Document is current
Any future updates will be listed below
-
Authors
Westerberg, Marcus https://orcid.org/0000-0002-8906-6967
Ludvigsson, Jonas F.
Metcalfe, Chris
Strömberg, Ulf
Blom, Johannes https://orcid.org/0000-0002-4938-6640
Engstrand, Lars
Hellström, Mikael https://orcid.org/0000-0003-4031-332X
Löwbeer, Christian
Steele, Robert
Holmberg, Lars
Forsberg, Anna https://orcid.org/0000-0002-7048-3357
- License Information
-
More Information
Article History
Received: 24 July 2025
Accepted: 12 January 2026
First Online: 20 February 2026
Competing interests
: J.F.L. has coordinated an unrelated study on behalf of the Swedish IBD quality register (SWIBREG). That study received funding from Janssen corporation. J.F.L. has also received financial support from Merck Sharp & Dohme/Merck for developing a paper reviewing national healthcare registers and has ongoing research collaboration on inflammatory bowel disease. J.F.L. has an ongoing research collaboration on celiac disease with Takeda Pharmaceuticals and has ongoing discussions for future research collaboration on liver disease with this company. The other authors declare no competing interests.
